Landos Biopharma Inc (LABP)
22.21
-0.09
(-0.40%)
USD |
NASDAQ |
May 20, 16:00
22.21
0.00 (0.00%)
After-Hours: 18:49
Landos Biopharma Shareholders Equity (Quarterly): 23.15M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 23.15M |
| December 31, 2023 | 31.79M |
| September 30, 2023 | 37.66M |
| June 30, 2023 | 43.27M |
| March 31, 2023 | 47.02M |
| December 31, 2022 | 39.13M |
| September 30, 2022 | 44.01M |
| June 30, 2022 | 51.53M |
| Date | Value |
|---|---|
| March 31, 2022 | 62.10M |
| December 31, 2021 | 76.27M |
| September 30, 2021 | 93.92M |
| June 30, 2021 | 105.61M |
| March 31, 2021 | 101.18M |
| December 31, 2020 | -54.02M |
| September 30, 2020 | -44.23M |
| December 31, 2019 | -25.58M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-54.02M
Minimum
Dec 2020
105.61M
Maximum
Jun 2021
39.55M
Average
43.64M
Median
Shareholders Equity (Quarterly) Benchmarks
| AbbVie Inc | 8.007B |
| Fusion Pharmaceuticals Inc | 241.83M |
| Masimo Corp | 1.365B |
| Kinnate Biopharma Inc (DELISTED) | 159.33M |
| Invivyd Inc | 178.50M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 29.90M |
| Total Liabilities (Quarterly) | 6.742M |